by The human platelet lysate market has gained traction over the past few years owing to the growing popularity and applications of regenerative medicine globally. Human platelet lysates are produced from human blood and are used as a substitute for fetal bovine serum in cell culture media. They improve cell growth and viability and help maintain stem cell potency in culture.
Some key advantages of human platelet lysates include their ability to support and promote cell growth and tissue regeneration. They provide growth factors, cytokines, and peptides essential for cultures. Their use eliminates concerns over unknown pathogens, allergens, and ethical issues associated with fetal bovine serum. They help advance large-scale production of stem cells and mesenchymal cells for research and therapeutic applications in regenerative medicine such as wound healing, bone growth, and cartilage repair.
The global Human Platelet Lysate Market is estimated to be valued at US$ 61.06 Bn in 2024 and is expected to exhibit a CAGR Of 9.4% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends observed in the market is increasing adoption of human platelet lysates in cell-based therapies and tissue engineering applications. Players are focusing on developing innovative platelet lysates tailored for specific cell types and therapeutic areas. For instance, companies are developing platelet lysates for mesenchymal stem cell expansion in bone regeneration and wound healing therapies. Growing demand for alternatives to fetal bovine serum and serum-free cell culture methods is expected to drive the demand for human platelet lysates over the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as establishing manufacturing facilities and obtaining regulatory approvals is an expensive and time consuming process which poses entry barriers.
Bargaining power of buyers: The bargaining power of buyers is high since the market comprises of many buyers including biotechnology companies, pharmaceutical companies and academic and research institutions that can bargain for lower prices.
Bargaining power of suppliers: The bargaining power of suppliers is moderate since they supply critical raw materials like platelets but established suppliers have a loyal customer base.
Threat of new substitutes: The threat of new substitutes is low as human platelet lysate is a promising cell culture supplement with no other suitable substitute available.
Competitive rivalry: The competitive rivalry is high due to the presence of many global and regional players offering products with identical features.
Key Takeaways
The Global Human Platelet Lysate Market Demand is expected to witness high growth over the forecast period.
Regional analysis:
North America holds the largest share of the global human platelet lysate market mainly due to strong biopharmaceutical industry presence, established healthcare infrastructure and growing demand for cell-based research in the region. The Asia Pacific region is anticipated to exhibit the highest growth rate during the forecast period attributable to growing focus on biologics research and manufacturing and expanding pharmaceutical sector in developing countries.
Key players:
Key players operating in the human platelet lysate market are Air Methods Corporation, Deccan Charters, Scandinavian Air Ambulance, Air Ambulance Specialists, Air Charter Service, Envision Healthcare Companies, Falck Danmark A/S, AMR Air Ambulance, AirMed International, and Express Aviation Services, ALPHASTAR. Air Methods Corporation and Envision Healthcare Companies are well-established leaders in the market due to their diverse services and global presence.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
